Applied Materials vs Lam Research AMAT vs LRCX
Applied Materials and Lam Research on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.
What differs most
- Consensus revenue growth for next year: Lam Research +50.7%, Applied Materials +21.1%.
- Return on equity: Lam Research 68.6%, Applied Materials 36.2%.
- Price / sales: Lam Research 14.2×, Applied Materials 10.5×.
- Trailing P/E: Lam Research 45.8×, Applied Materials 35.3×.
Price return
2025-10-16 → 2026-10-16
AMAT+79.7%
LRCX+85.4%
Profile
latestSector
Technology
Technology
Industry
Semiconductors
Semiconductors
Market value
$324.81B
$330.30B
Enterprise value
$325.52B
$329.28B
Employees
36,500
23,300
Revenue per employee (TTM)
$845K
$997K
Our models
nightlythe valuation on each stock's pagePrice vs model
89% overvalued vs model
147% overvalued vs model
Model range
$158–342
$81.36–158
Models in the headline
1
1
FCF growth priced in, at a 10% return
29.4%
32.7%
Every model, its assumptions and its range: AMAT valuation · LRCX valuation. The growth priced in, at any return: AMAT reverse DCF · LRCX reverse DCF.
Trading
close 2026-10-16Last close
$409.29
$263.94
52-week high
$723.00
$433.33
52-week low
$220.23
$139.59
Price vs 52-week high
−43.4%
−39.1%
Price vs 52-week low
+85.8%
+89.1%
Average daily volume / shares
1.0%
0.8%
Beta
1.59
1.85
Returns
to 2026-10-161 month
−1.5%
−2.0%
3 months
−27.0%
−17.8%
6 months
+5.0%
+1.1%
Year to date
+59.3%
+54.2%
1 year
+79.7%
+85.4%
1 year, dividends added
+80.6%
+86.2%
2 years
+121.7%
+256.0%
Valuation
AMAT price × TTM to Jul 2026 · LRCX price × FY2026P/E (TTM)
35.3×
45.8×
P/E on consensus EPS (next FY)
31.9×
27.7×
Price / sales
10.5×
14.2×
EV / sales
10.6×
14.2×
EV / EBITDA
—
38.1×
Price / book
12.7×
31.2×
Price / free cash flow (FY)
57.0×
67.5×
Free-cash-flow yield (FY)
1.8%
1.5%
Growth
AMAT TTM and FY2025 · LRCX TTM and FY2026Revenue growth (TTM)
—
+7.2%
Revenue growth, consensus next FY
+21.1%
+50.7%
Revenue, 3-year CAGR
3.2%
10.1%
Revenue, 5-year CAGR
10.5%
9.7%
EPS growth (TTM)
—
+8.9%
EPS growth, consensus next FY
+48.0%
+65.4%
EPS, 3-year CAGR
5.2%
20.1%
Free cash flow, 3-year CAGR
7.3%
1.5%
Diluted shares, 3-year change
−7.9%
−7.2%
Profitability
AMAT TTM to Jul 2026 · LRCX FY2026Gross margin (FY)†
48.7%
50.5%
Operating margin
29.6%
35.3%
EBITDA margin
—
37.2%
Net margin
30.1%
31.3%
Free-cash-flow margin (FY)
20.1%
21.1%
Return on equity
36.2%
68.6%
Return on assets
21.3%
34.9%
Asset turnover
0.71
1.12
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.
Balance sheet
AMAT MRQ Jul 2026 · LRCX MRQ Mar 2026Cash
$7.04B
$4.75B
Total debt
$7.74B
$3.73B
Net debt
$706.0M
−$1.02B
Debt / equity
0.3×
0.4×
Net debt / EBITDA (TTM)
—
-0.1×
Interest coverage (FY)
30.8×
0.0×
Current ratio (FY)
2.61
2.63
Dividends
trailing 12 monthsDividend yield
0.5%
0.4%
Dividends per share
$1.98
$1.11
Payout ratio (of TTM EPS)
17.1%
19.3%
Dividend per share, 5-year CAGR
16.6%
15.5%
Frequency
Quarterly
Quarterly
Ownership and activity
last 90 days · latest 13FTracked superinvestors holding (13F)
13
9
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$4.5M
$40.5M
Analyst upgrades
0
0
Analyst downgrades
1
0
Statements
AMAT income TTM to Jul 2026 · cash flow FY2025 · LRCX income FY2026 · cash flow FY2026Revenue
$30.84B
$23.23B
EBITDA
—
$8.64B
Operating income
$9.14B
$8.20B
Net income
$9.27B
$7.27B
EPS (diluted)
$11.58
$5.76
Operating cash flow
$7.96B
$5.86B
Capital expenditure
−$2.26B
−$966.4M
Free cash flow
$5.70B
$4.89B
Dividends paid
$1.38B
$1.27B
Keep comparing
Applied Materials against
Lam Research against
Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.